학술논문
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - The NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
Document Type
Article
Author
Source
In: BMC Cancer . (BMC Cancer, 29 December 2018, 18(1))
Subject
Language
English
ISSN
14712407